Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles

Acta Pharmaceutica

Volumn 54, Issue 2, 2004, Pages 103-118

  Reddy, Lakkireddy Harivardhan ^a   Murthy, Rayasa Ramachandra ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Dispersion polymerization; Drug release; Emulsion polymerization; Methotrexate; Nanoparticles; Particle properties; Poly(butylcyanoacrylate)

Indexed keywords

BUFFER; DEXTRAN; ENBUCRILATE; HYDROCHLORIC ACID; METHOTREXATE; MONOMER; NANOPARTICLE; POLY(BUTYL CYANOACRYLATE); UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; IN VITRO STUDY; INFRARED SPECTROSCOPY; PARTICLE SIZE; POLYMERIZATION; SYNTHESIS; TEMPERATURE; TIME; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 3242733120     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Bauduin and P. Speiser, Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties, J. Pharm. Pharmacol. 31 (1979) 331-332.
2. S. J. Douglas, L. Illum, S. S. Davis and J. Kreuter, Particle size and size distribution of poly-(butyl-2-cyanoacrylate) nanoparticles II. Influence of physicochemical factors, J. Colloid Interface Sci. 101 (1984) 149-157.
3. N. Behan and C. Birkinshaw, Mechanism of polymerization of butyl cyanoacrylate in aqueous dispersions, Macromol. Rapid Commun. 21 (2000) 884-886.
4. N. Behan, C. Birkinshaw and N. Clarke, Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerization and particle formation, Biomaterials 22 (2001) 1335-1344.
5. R. H. Muller, C. Lherm, J. Herbot, T. Blunk and P. Couvreur, Alkyl cyanoacrylate drug carriers: I. Physicochemical characterization of nanoparticles with different chain length, Int. J. Pharm. 84 (1992) 1-11.
6. I. Marchal-Heussler, P. Maincent, M. Hoffman, J. Spittler and P. Couvreur, Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutyl cyanoacrylate nanoparticle preparations, Int. J. Pharm. 58 (1990) 115-122.
7. N. Brasseur, D. Brault and P. Couvreur, Adsorption of hematoporphyrin onto polyalkyl cyanoacrylate nanoparticles: carrier capacity and drug release, Int. J. Pharm. 70 (1991) 129-135.
8. R. Gaspar, V. Preat and M. Roland, Nanoparticles of polyisohexyl cyanoacrylate (PIHCA) as carriers of primaquine: formulation, physico-chemical characterization and acute toxicity, Int. J. Pharm. 68 (1991) 111-119.
9. C. Verdun, P. Couvreur, H. Vranckx, V. Lenaerts and M. Roland, Development of a nanoparticle controlled-release formulation for human use, J. Control Rel. 3 (1986) 205-210.
10. L. H. V. Reddy and R. S. R. Murthy, Lymphatic transport of orally administered drugs, Ind. J. Exp. Biol. 40 (2002) 1097-1109.
11. C. J. H. Porter, Drug delivery to the lymphatic system, Crit. Rev. Ther. Drug Carrier Syst. 14 (1997) 333-393.
12. P. Jani, G. W. Halbert, J. Langridge and A. T. Florence, The uptake and translocation of latex nanospheres and microspheres after oral administration to rats, J. Pharm. Pharmacol. 41 (1989) 809-812.
13. P. Jani, G. W. Halbert, J. Langridge and A. T. Florence, Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency, J. Pharm Pharmacol. 42 (1990) 821-826.
14. Y. Takakura, S. Matsumoto, M. Hashida and H. Sezaki, Enhanced lymphatic delivery of mitomycin C conjugated with dextran, Cancer Res. 44 (1984) 2505-2510.
15. Y. Takakura, M. Kitajima, S. Matsumoto, M. Hashida and H. Sezaki, Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. I. Physicochemical characteristics and in vivo and in vitro antitumor activities, Int. J. Pharm. 37 (1987) 135-143.
16. F. A. Bovey, I. M. Kolthoff, A. I. Medalia and E. J. Meehan, Emulsion polymerization, Interscience publishers, New York 1955, pp. 1-22.
17. C. Dollery, Therapeutic Drugs, Churchill Livingstone Publishers, Edinburgh 1999, pp. M90-M96.
18. J. Kreuter, Physicochemical characterization of polyacrylic nartoparticle, Int. J. Pharm. 14 (1983) 43-58.
19. S. Bhawal, N. K. Pokhriyal and S. Devi, Translucent nanolatexes through emulsion polymerization of ethyl acrylate, Eur. Polymer J. 38 (2002) 735-744.
20. R. G. Gilbert, Emulsion Polymerization: A Mechanistic Approach, Academic Press, London 1995, pp. 1-25.
21. S. J. Douglas, L. Illum, S. S. Davis and J. Kreuter, Particle size and size distribution of poly-(butyl-2-cyanoacrylate) nanoparticles II. Influence of stabilizers, J. Colloid Interface Sci. 103 (1985) 154-163.
22. P. Edman, B. Ekman and I. Sjoholm, Immobilization of proteins in microspheres of biodegradable polyacryl dextran, J. Pharm. Sci. 69 (1980) 838-842.
23. A. E. Hawley, L. Illum and S. S. Davis, Lymph node localization of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers, FEBS Lett. 400 (1997) 319-323.
24. S. M. Moghimi, A. C. Hunter and J. C. Murray, Long-circulating and target-specific nanoparticles: Theory to practice, Pharmacol. Rev. 53 (2001) 283-318.
25. R. Duncan, Polymer conjugates for tumor targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. Tech. Today 2 (1999) 441-449.
26. H. Yoshikawa, K. Takada and S. Muranishi, Molecular weight dependence of permselectivity of rat small intestinal blood-lymph barrier for exogenous macromolecules absorbed from lumen, J. Pharmacobio. Dyn. 7 (1984) 1-6.
27. P. L. Ritger and N. A. Peppas, A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices, J. Control Rel. 5 (1987) 37-42.
28. P. Sommerfeld, U. Shroeder and B. A. Sabel, Long-term stability of PBCA nanoparticle suspensions suggests clinical usefulness, Int. J. Pharm. 155 (1997) 201-207.
29. B. A. Horwitz, M. Shintizky, W. Kreutz and M. B. Yatwin, pH sensitive liposomes: possible clinical implications, Science (Washigton DC) 210 (1980) 1253-1255.